Hormone-blocking drug reduces breast cancer risk
Saturday, June 4, 2011 - 13:00
in Health & Medicine
(AP) -- Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have curbed enthusiasm for other prevention drugs, a major study found.